The Tommy's Clinical Decision Tool, a device for reducing the clinical impact of placental dysfunction and preterm birth: protocol for a mixed-methods early implementation evaluation study.
Decision support
Implementation
Pregnancy
Preterm
Process evaluation
Risk assessment
Stillbirth
eHealth
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
15 Aug 2022
15 Aug 2022
Historique:
received:
05
05
2022
accepted:
23
06
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
18
8
2022
Statut:
epublish
Résumé
Disparities in stillbirth and preterm birth persist even after correction for ethnicity and social deprivation, demonstrating that there is wide geographical variation in the quality of care. To address this inequity, Tommy's National Centre for Maternity Improvement developed the Tommy's Clinical Decision Tool, which aims to support the provision of "the right care at the right time", personalising risk assessment and care according to best evidence. This web-based clinical decision tool assesses the risk of preterm birth and placental dysfunction more accurately than current methods, and recommends best evidenced-based care pathways in a format accessible to both women and healthcare professionals. It also provides links to reliable sources of pregnancy information for women. The aim of this study is to evaluate implementation of Tommy's Clinical Decision Tool in four early-adopter UK maternity services, to inform wider scale-up. The Tommy's Clinical Decision Tool has been developed involving maternity service users and healthcare professionals in partnership. This mixed-methods study will evaluate: maternity service user and provider acceptability and experience; barriers and facilitators to implementation; reach (whether particular groups are excluded and why), fidelity (degree to which the intervention is delivered as intended), and unintended consequences. Data will be gathered over 25 months through interviews, focus groups, questionnaires and through the Tommy's Clinical Decision Tool itself. The NASSS framework (Non-adoption or Abandonment of technology by individuals and difficulties achieving Scale-up, Spread and Sustainability) will inform data analysis. This paper describes the intervention, Tommy's Clinical Decision Tool, according to TiDIER guidelines, and the protocol for the early adopter implementation evaluation study. Findings will inform future scale up. This study was prospectively registered on the ISRCTN registry no. 13498237 , on 31
Sections du résumé
BACKGROUND
BACKGROUND
Disparities in stillbirth and preterm birth persist even after correction for ethnicity and social deprivation, demonstrating that there is wide geographical variation in the quality of care. To address this inequity, Tommy's National Centre for Maternity Improvement developed the Tommy's Clinical Decision Tool, which aims to support the provision of "the right care at the right time", personalising risk assessment and care according to best evidence. This web-based clinical decision tool assesses the risk of preterm birth and placental dysfunction more accurately than current methods, and recommends best evidenced-based care pathways in a format accessible to both women and healthcare professionals. It also provides links to reliable sources of pregnancy information for women. The aim of this study is to evaluate implementation of Tommy's Clinical Decision Tool in four early-adopter UK maternity services, to inform wider scale-up.
METHODS
METHODS
The Tommy's Clinical Decision Tool has been developed involving maternity service users and healthcare professionals in partnership. This mixed-methods study will evaluate: maternity service user and provider acceptability and experience; barriers and facilitators to implementation; reach (whether particular groups are excluded and why), fidelity (degree to which the intervention is delivered as intended), and unintended consequences. Data will be gathered over 25 months through interviews, focus groups, questionnaires and through the Tommy's Clinical Decision Tool itself. The NASSS framework (Non-adoption or Abandonment of technology by individuals and difficulties achieving Scale-up, Spread and Sustainability) will inform data analysis.
DISCUSSION
CONCLUSIONS
This paper describes the intervention, Tommy's Clinical Decision Tool, according to TiDIER guidelines, and the protocol for the early adopter implementation evaluation study. Findings will inform future scale up.
TRIAL REGISTRATION
BACKGROUND
This study was prospectively registered on the ISRCTN registry no. 13498237 , on 31
Identifiants
pubmed: 35971107
doi: 10.1186/s12884-022-04867-w
pii: 10.1186/s12884-022-04867-w
pmc: PMC9377101
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
639Subventions
Organisme : Tommy's
ID : Tommy's National Centre for Maternity Improvement
Informations de copyright
© 2022. The Author(s).
Références
N Engl J Med. 2017 Aug 17;377(7):613-622
pubmed: 28657417
Cochrane Database Syst Rev. 2017 Jun 06;6:CD008991
pubmed: 28586127
Ultrasound Obstet Gynecol. 2017 Sep;50(3):342-346
pubmed: 28436125
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Fetal Diagn Ther. 2019;45(6):381-393
pubmed: 30021205
JMIR Mhealth Uhealth. 2019 Apr 11;7(4):e11500
pubmed: 30973342
Acta Obstet Gynecol Scand. 2018 Aug;97(8):907-920
pubmed: 29663314
Lancet. 2021 Nov 20;398(10314):1905-1912
pubmed: 34735797
Am J Obstet Gynecol. 2018 Mar;218(3):287-293.e1
pubmed: 29138036
Ultrasound Obstet Gynecol. 2018 Jun;51(6):743-750
pubmed: 29536574
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Ultrasound Obstet Gynecol. 2020 Mar;55(3):357-367
pubmed: 31385343
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Syst Rev. 2017 Nov 28;6(1):235
pubmed: 29183399
Prenat Diagn. 2011 Jan;31(1):75-83
pubmed: 21210482
BJOG. 2021 Jan;128(2):149-156
pubmed: 32613730
PLoS One. 2021 Apr 19;16(4):e0250150
pubmed: 33872334
Evid Rep Technol Assess (Full Rep). 2012 Apr;(203):1-784
pubmed: 23126650
J Med Internet Res. 2017 Nov 01;19(11):e367
pubmed: 29092808
Glob Health Sci Pract. 2018 Oct 10;6(Suppl 1):S61-S71
pubmed: 30305340